It was a big week for Medtronic (NYSE:MDT) and its Symplicity high blood pressure device, with the release of 2-year clinical data and a pair of regulatory developments for the renal denervation system.
Cardiovascular Systems Inc.
Medtronic’s Irish profits rise 119% | Wall Street Beat
UPDATE: Cardiovascular Systems closes enrollment in Diamondback trial
UPDATED Nov. 27, 2012, with comment from Leerink Swann analyst Danielle Antalffy, closing share price.
Cardiovascular Systems (NSDQ:CSII) said it’s enrolled the 443rd and final patient in a clinical trial of its Diamondback 360 atherectomy device for clearing calcium deposits from blood vessels.
Incoming BSX CEO Mahoney’s 2011 total tops $11.5M | Personnel Moves
Device tax spurs Hill-Rom to lay off 200 | Wall Street Beat
Hill-Rom Holdings (NYSE:HRC) said it will lay off about 3% of its workforce, or roughly 200 workers, as it maneuvers to confront the medical device tax set to go into effect next year.
ACC roundup: The top headlines from today’s meeting of American College of Cardiology
Thoratec soars after killing it in Q3 | Earnings Roundup
Thoratec (NSDQ:THOR) shares are up more than 11% today after the heart pump maker put mid-double-digit profit growth numbers on the board for the 4th quarter and full-year 2011.
The Pleasanton, Calif.-based cardiac assist device maker logged profits of $15.3 million, or 25 cents per diluted share, on sales of $109.4 million for the 3 months ended Dec. 31, 2011. That’s a 46.4% bottom-line gain and a top-line boost of 12.1%, compared with profits of $10.5 million, or 17 cents diluted EPS, on sales of $97.6 million during Q4 2010.
Merck to invest up to $17M in Physicians Interactive | Funding Roundup
Merck Global Health Innovation Fund will invest up to $17 million in medical app maker Physicians Interactive Holdings. The financing includes $8.5 million up front, but could double if the mHealth marketer meets Merck’s milestones.
The Marlborough, Mass.-based company plans to use the Merck funds to grow "4 key products," including its flagship medical resources app Skyscape.
FDA clears Philips combination PET/MR scanner | Regulatory Roundup
Philips Ingenuity Scanner
Philips Healthcare (NYSE:PHG) landed 510(k) clearance from the FDA to market its Ingenuity whole-body PET/MR imaging system in the U.S.
The scanner performs both PET and magnetic resonance imaging scans, allowing doctors to acquire images at a significantly lower radiation dose than traditional PET/computer tomography scanners, which use x-rays to make images.
TCT 2011: Three ways to spur U.S. medical innovation
The U.S. medical device arena is in danger of ceding the throne to countries with friendlier regulatory environments but the system is not irreparable, Dr. Martin Leon said during a lecture at this week’s Transcatheter Cardiovascular Therapeutics symposium in San Francisco.
AngioDynamics’ Q1 sales rise, profits slump | Wall Street Beat
AngioDynamics (NSDQ:ANGO) saw its first-quarter profits slump despite posting a 5.7 percent top-line increase during the three months ended August 31.
The Albany, N.Y.-based medical device maker reported net income of $1.4 million, or 5 cents per share, on sales of $54.4 million for the quarter. That compares with profits of $1.9 million, or 8 cents EPS, on sales of $51.5 million during the same period last year.